Potential ROW Partnership for MIRV? | IMGN Message Board Posts


ImmunoGen, Inc.

  IMGN website

IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  52179 of 52340  at  5/15/2021 11:33:06 AM  by

Biotechbeagle


 In response to msg 52178 by  EFJ61
view thread

Re: Potential ROW Partnership for MIRV?

Marketing, sales or licensing agreements Typically come after FDA approval. Need the label clearly defined to
Determine the TAM. partnerships prior to an fda are based on co-development of the product to defray costs. IMGN situation for MIrve situation is the prior where 632 was the later. Since most of our combo therapies are generic, we will most likely partner with a PARP partner like AZ or Glaxo that wants to own the ovarian channel or a distributor of generic chemo therapies is my guess. Seeing that they need money, an outright acquisition is most certainly on the table. In an acquisition Woukd be a suitor that has both an HBOC and AML sales force.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...